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1. Introduction
Colorectal cancer is a common gastrointestinal malignancy in the USA, Europe, and Japan.
Most colorectal cancers are thought to arise from preexisting adenomas based on the concept of
the adenoma-carcinoma sequence [1]. Chromoendoscopy, using Kudo and Tsuruta’s pit pat‐
tern classification, is an efficient tool for the differential diagnosis of colorectal polyps [2-4]. Re‐
cently, image-enhanced endoscopy (IEE) has been used for diagnosing gastrointestinal tumors
[5-7]. Endoscopic therapy, including endoscopic mucosal resection (EMR) and endoscopic sub‐
mucosal dissection (ESD), is used worldwide to treat adenoma and early colorectal cancer
[8-10]. In this chapter, we demonstrated the effectiveness of IEE and discuss strategies of thera‐
peutic endoscopy including EMR and ESD.
2. Image-enhanced endoscopy
Colonoscopy is accepted as an efficient examination for the detection of neoplastic colorectal le‐
sions. However, the diagnostic capability of white-light endoscopy (WL) for the differentiation
of neoplastic and non-neoplastic polyps shows low sensitivity (38–76%) and variable specificity
(66–97%) [11-13]. On the other hand, chromoendoscopy has demonstrated high sensitivity
(96.3–97.0%) and specificity (93.5–100%) for the differentiation of neoplastic and non-neoplastic
polyps [10,11]. However, chromoendoscopy is time-consuming. Now, image-enhanced endos‐
copy (IEE) is used to diagnose gastrointestinal tumors. This method is a change from conven‐
tional WL endoscopy, and requires no dye. It only requires the push of a button. IEE such as
narrow band imaging (NBI), flexible spectral imaging color enhancement (FICE), and auto‐
fluorescence imaging (AFI) offer many advantages for diagnosis of neoplastic tumors, evalua‐
tion  of  invasion  depth  of  cancerous  lesions,  and  detection  of  neoplastic  lesions.  We
© 2013 Yoshida et al.; licensee InTech. This is an open access article distributed under the terms of the
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demonstrated the efficacy of IEE for diagnosis of colorectal tumors in view of endoscopic treat‐
ment options.
3. NBI, FICE, and AFI systems
With the NBI system (Olympus Medical Co., Tokyo, Japan), optical filters that allow nar‐
row-band light to pass at wavelengths of 415 and 540 nm are mechanically inserted be‐
tween  a  xenon lamp and a  red/green/blue  rotation  filter  [12-15].  Narrow vessels  at  the
mucosal surface can be seen most clearly at 415 nm, which is the wavelength that corre‐
sponds to the hemoglobin absorption band, while thick vessels in the deep layer of  the
mucosa can be detected at 540 nm. Thus, NBI can enhance vascular patterns [Figure 1].
Moreover, NBI can detect pit like structures, which have been recognized as surface pat‐
terns by a Japanese consensus symposium [16].
Figure 1. NBI with magnification. 1a: 0-IIa polyp, 20 mm in diameter. White-light endoscopy image. 1b: Mucosal capil‐
lary and irregular surface pattern were detected by NBI with magnification. The polyp was diagnosed as a neoplastic
polyp.
The FICE system (Fujifilm Medical Co.,  Tokyo, Japan) is another type of IEE, but is un‐
like NBI. FICE was formerly known as Fuji Intelligent Color Endoscopy, but this defini‐
tion  has  recently  changed.  FICE  depends  on  optical  filters  and  spectral-estimation
technology to  reconstruct  images  at  different  wavelengths  based on WL images  [17,18].
The suitable RGB wavelength settings and contrast levels for FICE to evaluate colorectal
polyps are 540 (1) nm, 460 (4) nm, and 460 (4) nm, respectively [19,20]. FICE can display
color  images in real  time with RGB components  that  have been assigned selected spec‐
tra. FICE can enhance vascular and surface patterns (Figure 2)[19-23]. AFI videoendosco‐
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py  (Olympus  Medical  Co.,  Tokyo,  Japan)  is  comprised  of  a  blue  light  to  provoke
emissions and a green light for hemoglobin absorption [24-26].  Neoplastic  areas involve
a thickening of the mucosal layer and increased hemoglobin, and so are expected to ex‐
hibit weaker autofluorescence compared to non-neoplastic areas (Figure 3).
Figure 2. FICE with magnification. 2a: 0-Isp polyp 12 mm in diameter. White-light endoscopy image. 2b: Mucosal capillary
and surface pattern were detected with FICE with magnification. The polyp was diagnosed as a neoplastic polyp.
Figure 3. AFI. 3a. 0-IIa polyp 20 mm in diameter. White-light endoscoy image. 3b. In AFI, the normal mucosa is detect‐
ed by green color and the neoplastic polyp was detected by magenta color.
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4. Clinical advantages of NBI and FICE
Magnifying endoscopy (ME) is uncommon in the USA and Europe. Therefore, accurate
diagnosis of colorectal polyps through endoscopy without magnification is required. In NBI,
high-definition colonoscopy without magnification has been able to predict whether a
colorectal polyp is neoplastic or non-neoplastic [26, 27]. A meshed capillary network is one of
the important endoscopic features of neoplastic polyps in NBI without magnification, as
described by Sano et al. [5] (Figure 4). Rex [28] adopted a surface pattern including pit and
vascular pattern for neoplastic features in NBI, and Rastogi et al. used 5 different surface
patterns (including mucosal, pit, and vascular patterns) to differentiate neoplastic polyps from
non-neoplastic polyps [11]. In various studies, NBI without magnification had an accuracy of
89–92.7%, sensitivity of 87.9–95.7%, and specificity of 87–90.5% (Table 1) [26-30].
Figure 4. NBI without magnification. 4a: 0-Isp polyp 6 mm in diameter. White-light endoscopy image. 2b: Meshed
capillary pattern was detected with NBI without magnification. The polyp was diagnosed as a neoplastic polyp. 4c: 0-Is
polyp 3 mm in diameter. White-light endoscopy image. 4d: Meshed capillary pattern was detected with NBI without
magnification. The polyp was diagnosed as a neoplastic polyp.
FICE without magnification is also reported to be useful for differentiation between neoplastic
and non-neoplastic polyps. The detection of surface patterns by FICE is a reliable method to
determine whether a polyp is neoplastic or non-neoplastic, and evaluation of vascular pattern
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has also been described (Figure 5) [19]. In various studies, FICE without magnification has
demonstrated an accuracy of 84.4–89.4%, sensitivity of 89.4–93.2%, and specificity of 81.2–88%,
similar to the findings for NBI (Table 1) [19,30].
Author System No. of cases Accuracy (%) Sensitivity (%) Specificity (%)
Henry ZH et al NBI 126 90.0 93.0 88.0
Su MY et al NBI 110 92.7 95.7 87.5
Tischendorf JJW et
al
NBI 100 89.0 87.9 90.5
Rex DK NBI 451 89.0 92.0 87.0
Lonqcroft-Wheaton
GR
FICE 232 88.0 - -
Pohl J et al FICE 321 84.4 93.2 61.2
Yoshida N et al FICE 151 89.4 89.4 88.0
Sato R et al AFI 358 91.9 92.7 92.9
NBI: narrow-band imaging, FICE: flexible spectral imaging color enhancement
Table 1. Reports of image-enhanced endoscopy without magnification for the differentiation of neoplastic and non-
neoplastic polyps
When polyp size is considered, the accuracy of NBI without magnification for Polyps 10mm
or greater in diameter (accuracy: 96.0%) were greater than those for polyps 5 mm or less in
diameter (accuracy: 90.0%) [27]. In FICE without magnification, the accuracy, sensitivity, and
specificity for polyps 6 mm or greater in diameter (97.1%, 95.2%, 90%, respectively) are greater
than those for polyps 5 mm or less in diameter (82.7%, 78.0%, 87.5%) [18,32]. Diagnosis of small
polyps is important for the prevention of colorectal cancer. A procedural decision to avoid
resection of non-neoplastic polyps would spare patients the cost and risk of a polypectomy
that serves no useful purpose.
Recently, an international cooperative group, the Colon Tumor NBI Interest Group, was
formed. The group consists of members from Japan, the USA, and Europe, and it has developed
the NBI international colorectal endoscopic (NICE) classification, which classifies colorectal
tumors into types 1–3 and is even applicable to colorectal tumors closely observed without
magnification (Table 2) [16]. NICE types 1 and 3 are mainly observed in hyperplastic polyps
and massively invasive submucosal cancer, respectively. NICE Type2 is observed in various
histopathological types such as adenoma, intramucosal cancer, and less invasive submucosal
cancer. The NICE classification with or without magnification is considered valid in the USA,
Europe, and Japan for differentiating neoplastic and non-neoplastic polyps [33].
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Figure 5. FICE without magnification. 5a: 0-Isp polyp 5 mm in diameter. 5b: Image of FICE without magnification. Tub‐
ular and oval pits were identified as neoplastic surface patterns. Vascular patterns were detected. 5c: 0-Is polyp 3 mm
in diameter. 5d: Image of FICE without magnification. Round pits were identified as non-neoplastic surface patterns.
Type 1 Type 2 Type 3
Color Same or lighter than
background
Browner relative to
background (verify color arises
from vessels)
Brown to dark brown relative
to background; sometimes
patchy whiter areas
Vascular
pattern
None, or isolated lacy vessels
may be present coursing
across the lesion
Thick brown vessels
surrounding white structures
Has area(s) with markedly
distorted or missing vessels
Surface
Pattern
Dark or white spots of
uniform size, or homogenous
absence of pattern
Oval, tubular or branched
white structures surrounded
by brown vessels
Areas of distortion or absence
of pattern
Table 2. NICE classification
Regarding of IEE-ME techniques, there have been many studies on both NBI-ME and FICE-
ME [12, 13, 17, 23, 34-36]. These studies have reported accuracy of 93.4–98.9%, sensitivity of
90.9–100%, specificity of 75–98.9%, PPV of 91.2–97.3%, and NPV of 90–100% for the differen‐
tiation of neoplastic and non-neoplastic lesions (Table 3). There are 4 published classifications
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of NBI-ME, including the Sano classification, the Hiroshima classification, the Showa Classi‐
fication, and the Jikei Classification, and 1 published classification for FICE-ME [15, 16, 23, 34,
37]. In brief, the Sano classification, Showa classification, and Jikei classification are based only
on vascular patterns, while the Hiroshima classification and FICE classification use surface
and vascular patterns. The efficacy of surface pattern detection in NBI and FICE with magni‐
fication has been reported [16, 23].
Author System No. of cases Accuracy (%) Sensitivity (%) Specificity (%)
Machida H et al NBI 43 93.4 100.0 75.0
Sano Y et al NBI 150 95.3 96.4 92.3
Wada Y et al NBI 617 96.7 90.9 97.1
Tanaka S et al NBI 289 98.9 100.0 98.9
Togashi K et al FICE 107 87.0 93.0 70.0
Santos CE et al FICE 111 92.8 97.8 79.3
NBI: narrow-band imaging, FICE: flexible spectral imaging color enhancement
Table 3. Reports of image-enhanced endoscopy with magnification for differentiation of neoplastic and non-
neoplastic polyps
The accuracy, sensitivity, and specificity of each NBI and FICE classification for massively
invasive submucosal cancer are described in Table 4 [15, 16, 23, 34, 37]. Accuracy of 87.7–98.3%,
sensitivity of 63.8–100%, specificity of 88.7–100%, PPV of 71.8–100%, and NPV of 90–96.2%
have been reported. NBI and FICE with magnification are thought to be useful for directing
therapeutic strategies, including endoscopic resection by EMR, ESD, or surgery for colorectal
tumors. However, the sensitivity (63.8%–100%) and specificity (88.7–100%) are not enough.
Chromoendoscopy using the pit pattern classification should be performed when a lesion
suspected as cancerous is detected with NBI and FICE or is diagnosed by NBI and FICE with
low confidence. The following sections contain details of 2 of the published NBI classifications.
Author System No. of cases Accuracy (%) Sensitivity (%) Specificity (%)
Wada Y et al NBI 584 96.1 100.0 95.8
Tanaka S et al NBI 97 94.1 63.8 100.0
Ikematsu H et al NBI 130 87.7 84.8 88.7
Yoshida N et al FICE 124 98.3 77.7 100.0
Saito S et al NBI 291 88.7 95.6 77.3
NBI: narrow-band imaging, FICE: flexible spectral imaging color enhancement
Table 4. Reports of image-enhanced endoscopy with magnification for identification of massively invasive
submucosal cancer
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5. Sano classification (Figure 6) [5, 15]
This classification is based on the surface characteristics of the meshed capillaries. Capillary
pattern (CP) type I indicates that there is no meshed capillary pattern visible, as in hyperplastic
polyps. CP type II describes the regular small caliber capillaries observed in adenomatous
polyps. CP type III is defined as an irregular and unarranged pattern in a mesh-like micro‐
vascular architecture that exhibits at least 1 of the following: irregular size, complicated
branching, or disrupted irregular winding [35]. CP type III lesions are further classified into 2
groups, IIIA or IIIB, according to microvascular architecture and microvessel density with lack
of uniformity and blind endings, branching and irregularly curtailed. CP type IIIA is observed
mainly in adenoma, intramucosal cancer, and less invasive submucosal cancers. CP type IIIB
was reported in 28% of intramucosal cancers and 72% of massively invasive submucosal
cancers.
Figure 6. NBI classification. 6a. CP Type I in Sano classification. Type A in Hiroshima classification. 6b. CP Type II in Sano
classification. Type B in Hiroshima classification. 6c. CP Type IIIA in Sano classification. Type C-1 in Hiroshima classifica‐
tion. 6d. CP Type IIIB in Sano classification. Type C-2 in Hiroshima classification. 6e. CP Type IIIB in Sano classification.
Type C-3 in Hiroshima classification.
6. Hiroshima classification (Figure 6) [13]
The Hiroshima classification is based on vascular patterns and surface patterns, and includes
type A, type B, or type C. Type A indicates that microvessels are not observed or are extremely
opaque. In type B, fine microvessels are observed around surface patterns, and clear pits are
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observed via the nest of microvessels. In type C, the microvessels are irregular and the vessel
diameter or distribution is heterogeneous. Type A is observed in hyperplastic polyps and type
B is observed mainly in adenoma. Type C is divided into 3 subtypes (C1, C2, and C3), according
to surface pattern’s visibility, vessel diameter, irregularity, and distribution. In type C1,
microvessels comprise an irregular network, surface patterns observed via the microvessels
are slightly nondistinct, and vessel diameter or distribution is homogeneous. Type C1 has been
reported in 46.7% of adenomas, 42.2% of intramucosal cancers, and 11.1% of massively invaded
submucosal cancers. In type C2, microvessels comprise an irregular network, surface patterns
observed via the microvessels are irregular, and vessel diameter or distribution is heteroge‐
neous. Type C2 was observed in 45.5% of intramucosal cancers and 54.5% of massively invaded
submucosal cancer. In type C3, surface patterns cannot be observed via the microvessels,
irregular vessel diameter is thick, or the vessel distribution is heterogeneous, and avascular
areas are seen. Type C3 is mainly found in massively invaded submucosal cancer.
7. Blue laser imaging by laser light source: A novel IEE
A newer endoscope system, “LASEREO,” developed by Fujifilm, uses a semiconductor laser
as a light source. It has narrow-bandwidth observation capability. The LASEREO system has
2 kinds of lasers. One laser provokes phosphor-illumination with a wavelength of 450 nm,
similar to that of a xenon lamp. The combination of laser and fluorescent light provides an
illumination that is almost equal to that of WL [Figure 7a]. The other laser is the “blue laser
image (BLI),” which functions as a narrow-band light and has a wavelength of 410 nm [Figure
7b]. BLI is useful for acquiring mucosal surface information including surface blood vessel and
structure patterns [Figure 7c]. By controlling the power of the 2 lasers, a BLI-bright mode is
set by an appropriate combination of WL and BLI light. This mode is brighter than the BLI
mode alone, and it is useful for tumor detection and observation of whole tumors.
Figure 7. BLI. 7a. 0-Isp 12 mm with BLI. 7b. BLI-bright mode. 7c. Vascular pattern and surface pattern were detected
clearly. CP type IIIB in Sano classification. Type C2 in the NBI classification (Hiroshima classification).
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8. Adenoma detection rate
Colonoscopy is considered to be the standard examination against which the sensitivity of
other colorectal cancer screening tests is compared [38,39]. A meta-analysis of 6 studies found
that the missed polyp rate for polyps of any size was 22% [40]. The study also demonstrated
that the missed adenoma rates were 2%, 13%, and 26% for polyp sizes of 10 mm <, 5–10 mm,
and 1–5 mm respectively [41]. The reasons for missed polyps included the quality of bowel
preparation, lesion characteristics (location, number, shape, and size), the endoscopist's
experience, and the operator's insertion and withdrawal techniques [41-44]. Although many
clinical studies, including randomized controlled trials (RCTs), have confirmed reduced
missed rates in colonoscopy using NBI techniques [45-52], one recent meta-analysis revealed
that there was no statistically significant difference in the rates of adenoma detection rate
between NBI and WL [53], and a large-scale multicenter Japanese study did not show an
improvement with NBI [54]. Moreover, another systematic review including 8 RCTs showed
that NBI did not improve detection of colorectal polyps when compared to WL [55]. For FICE,
2 RCTs showed that any objective improvement of FICE was not correlated with the adenoma
detection rate [56,57]. On the other hand, NBI and FICE systems have been improved recently
and the recent combination of both systems and endoscopy employ high resolution and
provide better contrast for vascular and surface patterns in ME than previous systems.
9. Endoscopic mucosal resection
Endoscopic mucosal resection (EMR) is now performed worldwide for early colorectal cancers.
The saline injection-assisted method was first described by Rosenberg, who identified it as a
safe method for the removal of rectal and sigmoid polyps, and was reintroduced by Tada et
al. in 1984 [58-59]. Most adenomas and intramucosal cancers can be resected by EMR, however,
tumors greater than 20 mm in diameter are considered difficult candidates for en bloc resection
[60-65], and the rate of en bloc resection by EMR of tumors >20 mm in diameter is especially
low (Table 5)[60-65]. While the technical feasibility of EMR for en-bloc and extended resections
must still be improved, most colorectal polyps removed by EMR are <20 mm in size. EMR
achieves en-bloc and complete resection of these lesions at satisfactory rates, although even
some smaller lesions are difficult to resect completely, especially for less-experienced endo‐
scopists. Many injection solutions have been used to achieve sustained mucosal elevation,
definitive en-bloc resection, and complete resection while preventing perforation during EMR.
Hypertonic saline, glycerol, dextrose, fibrinogen, and succinylated gelatin provide better
complete resection rates and longer-lasting mucosal elevation than does normal saline (NS)
[65-69]. Yamamoto et al. first reported the efficacy of hyaluronic acid (HA) for novel endoscopic
resection of a large colorectal polyp, and this procedure was subsequently termed endoscopic
submucosal dissection (ESD) [68]. Hyaluronic acid (HA) has been shown to create higher and
more sustainable mucosal elevation than NS [68,70-72]. We have previously reported that
mucosal elevation with NS dissipates within 2 min from injection, which is the median time
required for most endoscopists to perform an EMR [69]. Our same study found that the
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viscosity of high-concentration HA can make snaring difficult. For this reason, and because
HA is more expensive than NS, it is important to dilute HA prior to use. We have previously
demonstrated that an HA concentration as low as 0.13% is effective for sustained mucosal
elevation in resected porcine colon and in living minipig colon [69]. Moreover, we previously
reported a prospective RCT concerning the efficacy of 0.13% HA in colorectal EMR that proved
that using 0.13% HA instead of NS during EMR was more effective for complete resection and
maintenance of mucosal elevation [73].
Author Injection
Solution
No. of cases Rate of En bloc
resection (%)
Rate of local
recurrence (%)
Saito et al. not
described
228 33.0 14.0
Tanaka et al. Glycerol 178 39.3 7.9
Tajika et al. 104 48.1 15.4
Iishi et al. NS 56 25 not described
Kobayashi et al. 56 37.5 21.4
Uraoka et al. NS
Glycerol
44
39
20.5
23.1
18.6
15.2
Our data HA 35 42.8 10.0
NS: normal saline, HA: hyaluronic acid
Table 5. Rates of en bloc resection and local recurrence of tumors larger than 20 mm in diameter treated by
endoscopic mucosal resection (EMR)
Evaluation of  en bloc resection is  performed endoscopically,  while complete resection is
defined  histopathologically  based  on  the  tumor-free  lateral  and  vertical  margins  of  the
resected  specimens.  However  some  specimens  resected  by  EMR  have  positive  margins
even  after  the  tumor  was  grossly  resected  en  bloc.  Burning  of  the  resected  specimens
may affect these results, and although most such tumors cause no local recurrence, some
do recur locally.  Therefore,  endoscopists  are obligated to perform EMR with tumor-free
margins [74]. We describe a regular method of EMR to obtain complete resection of pol‐
yps.  Firstly,  polyp  and  margin  are  observed  carefully  and  then  injection  is  performed
[Figure 8].  The recommended locus of injection is the proximal side of the polyp. If  the
injection is performed at the distal (anal) side of the polyp, the polyp may shift to a hori‐
zontal  position  to  the  endoscope.  In  this  situation,  the  margin  of  the  tumor  cannot  be
confirmed.  After  injection,  snaring  is  performed  and  polyp  is  resected  with  electrocau‐
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tery. After resection, endoscopic clipping is sometimes performed to prevent post-opera‐
tive hemorrhage and perforation.
Figure 8. Strategy of EMR. 8a. Polyp and margin of it are observed carefully. 8b. Injection is performed at the oral
(proximal) side of the polyp. 8c. Snaring is performed. 8d. Polyp is resected by electrocautery.
When en bloc resection of the tumor by EMR fails, piecemeal EMR is generally performed
instead. Although piecemeal EMR enables the removal of large colorectal tumors, it has a high
rate of local recurrence (7.9–21.4%)[60-65] (Table 5). Most recurrent adenomas, including
partial intramucosal adenocarcinomas, can be cured by additional endoscopic therapy [74]. If
possible, The use of piecemeal EMR should be examined carefully before endoscopic therapy
by ME and IEE. In some cases, piecemeal EMR does not allow for precise histopathological
evaluation. For example, partial submucosal invasion in submucosally invasive cancer can be
missed in piecemeal-resected specimens. When the locus of submucosal invasion in submu‐
cosally invasive cancer is destroyed by burning, the tumor may be misdiagnosed as mucosal
cancer, and when the positive vertical margin of submucosal or lymphatic-venous invasion is
burned, the resection may misclassified as complete [74]. In these cases, the patient will not be
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advised to undergo additional surgical resection, allowing recurrence a few years later.
Recurrence may occur as lung, liver, and/or lymph node metastasis, and these patients are
very difficult to cure.
10. Endoscopic submucosal dissection
In Japan and some other Western and Asian countries, endoscopic submucosal dissection
(ESD) is reported to be an efficient treatment with a high rate of en bloc resection for large
colorectal tumors and it is considered less invasive than laparoscopic colectomy (LAC) [75-83].
However, ESD can be a time-consuming procedure and carries a higher risk of perforation
than EMR [81,82]. The use of ESD was initially proposed by the Japanese special ESD group
[80]. Indications in detail are, first, large lesions >20 mm in diameter for which endoscopic
therapy is indicated but for which en bloc resection by snare EMR would be difficult. Second,
lesions that are suspected as invasive submucosal cancer should be resected en bloc by ESD.
Thirdly, lesions other than these cases can be an indication for ESD, including mucosal lesions
with fibrosis caused by prolapse due to biopsy or peristalsis of the lesions, local residual early
cancer after endoscopic resection, and sporadic localized tumors in chronic inflammation such
as ulcerative colitis. The rate of en bloc resection for large colorectal tumors by ESD has been
reported to be 80–98.9%[75-83](Table 6). However, the procedure has not been standardized
because of its associated technical difficulties. The colon is winding in nature and has many
folds. Moreover, the wall of the colon is thinner than the gastric wall.
Author No. of cases Rate of En bloc
resection (%)
Perforation rate
(%)
Post-operative
bleeding rate (%)
Saito et al. 1111 88.0 4.9 1.5
Toyonaga et al. 468 98.9 1.5 1.5
Isomoto et al. 292 90.1 8.2 0.7
Yoshida et al. 250 86.8 6.0 2.4
Fujishiro et al. 200 91.5 10.4 1.0
Zhou et al. 74 93.2 8.1 1.3
Tanaka et al. 70 80.0 10.0 1.4
Our recent data 410 92.6 4.1 1.9
Table 6. Rates of en bloc resection and complete resection by endoscopic submucosal dissection (ESD)
We describe standard ESD devices here. ESD is performed with a regular lower gastrointestinal
endoscope with a single channel. In our institution, colonoscopes with single channels such as
the EC 590 MP (Fujifilm Medical, Tokyo, Japan) or the PCF Q260AI (Olympus, Tokyo, Japan)
are used. With regard to the choice of endoscope, an upper gastrointestinal endoscope is
preferred in some institutions because it is slim and can be used in the retroflexed position [78].
ESD requires a high-frequency generator with an automatically controlled system. A trans‐
parent short hood (Olympus Medical Systems, Co. Ltd.) is fitted at the tip of the endoscope.
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This helps the easy placement of endoscope during ESD. A mixture of 0.4% hyaluronic acid
solution (Mucoup; Johnson & Johnson K.K., Tokyo, Japan and Seikagaku Corporation, Tokyo,
Japan) is used as the injection liquid to induce a greater elevation of the submucosa and to
lengthen the duration of the continuous elevation of the submucosa [77, 82].
Various knives are used in ESD for excising colorectal tumors (Figure 9). Among the obtuse
short-tipped types are included the Flush knife (Fujifilm Medical, Tokyo, Japan), Dual knife
(Olympus Optical Co, Tokyo, Japan), B-knife (Zeon Medical, Tokyo, Japan), and Splash needle
(Pentax Co, Tokyo, Japan) [75, 82]. The Flush knife and Splash needle are capable of submu‐
cosal injections and they allow the endoscopist to omit switching between the knife and the
injection needle [75, 83]. The Dual knife, B-knife, and Flush knife all have a ball disk at the tip
of the knife, enabling the operator to hook the submucosa. The insulated tipped (IT) knife
(Olympus Optical Co, Tokyo, Japan), whose efficacy has been reported to be satisfactory in
ESD for gastric tumors, is being used in certain institutions [84]. The IT knife allows rapid
dissection. A Hook knife (Olympus Optical Co, Tokyo, Japan) is particularly useful when the
dissection of the submucosa is difficult due to poor elevation of the submucosa [80]. The B-
knife is the only bipolar knife, and there is thought to be less burning of the muscularis propria
layer with this knife than with other monopolar knives. The clutch cutter (Fujifilm medical,
Tokyo, Japan) and SB knife (Sumitomo Bakelite Co., Tokyo, Japan) are grasping-type scissor
forceps [85-86]. In our institution, the Flush knife is mainly used because it can effectively
administer local injections, and the clutch cutter is used when the risk of perforation is high
due to the poor elevation of the submucosa [74,85].
Following are the steps of the routine ESD procedure (Figure 10) [82,87]. Before ESD, residual
feces and liquid are removed from the entire colon even if the tumor is located at the rectum.
Residual feces prevent smooth submucosal dissection. Moreover, it is essential to remove
residual feces in order to prevent the outflow of feces into the abdomen in the case of perfo‐
ration. Firstly, the border of the tumor is carefully identified using indigo carmine dye. It is
generally unnecessary to mark the borders by coagulation because in the majority of cases they
are clearly visible. Injection for submucosal elevation is performed with a 25G needle (8B27A,
TOP, Tokyo, Japan) after visualization of the border of the tumor, and mucosal incisions are
made. A partial circumferential incision is made on the distal side of the tumor [77, 80]. If the
size of the tumor exceeds 50 mm, the incision is performed at the proximal side of the tumor,
because in large tumors it is sometimes difficult to resect residual mucosa on the proximal side
in the presence of a partially resected tumor. Mucosal incisions are made only after adequate
elevation of submucosa by mucosal injection is achieved, and then, simultaneously, an incision
into the deep submucosa is made. Mucosal incisions are performed with the endocut mode
(output 40 W, effect 2 in ICC200; or endocut I, effect 2, duration 2, interval 1 in VIO300D).
After mucosal and submucosal incisions are made at the anal side of the tumor, the submucosa
below the tumor is resected from the distal side of the tumor. Dissection of the submucosa is
performed using the endocut (output 40 W, effect 2 in ICC200; endocut I, effect 2, duration 2,
interval 1 in VIO300D) or coagulation mode (forced coagulation, output 40 W in ICC200 or
forced coagulation, output 40 W, effect 3 in VIO300D). To achieve submucosal elevation,
additional injections are performed with the injection needle or flush knife, as appropriate.
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Then continuing to dissect while carefully avoiding perforation and hemorrhage, en bloc
resection of the tumor is completed.
Figure 9. Various ESD knives.
The main complications of ESD are perforation and hemorrhage, similar to those of endoscopic
mucosal resection (EMR). In particular, the rate of perforation is higher for ESD than for EMR
(1.5–10.4%)(Table 6)[75-83]. Perforation of the colon can cause fatal peritonitis. Coagulation by
knife is the most frequent cause of perforation [81]. Saito et al. showed that perforation risk
was related to the number of ESD procedures, with higher risk when the endoscopist had
performed fewer than 100 procedures [83]. Most cases of perforation are treated conservatively
by endoscopic clipping, without need for urgent surgical intervention [40,41] (Figure 11).
Carbon dioxide insufflations have been reported to be effective for the prevention of abdominal
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fullness [88]. They also has been reported to be effective for prevention of perforation by
decreasing pressure in the colorectum. On the other hand, the rates of postoperative hemor‐
rhage are similar for ESD and EMR. When hemorrhage occurs, endoscopic therapy, including
endoscopic clipping, is performed, and most cases, can be managed conservatively and
without blood transfusion. A safe strategy, suitable knife, adoption of other equipment, and
training in animal models are necessary in order to minimize the complications, including
perforation, of ESD [42].
Figure 10. Strategy of ESD. 10a. 0–IIa 30 mm on the descending colon. Firstly, the tumor and margin of it are observed
carefully. 10b. Injection is performed at the anal (distal) side of the tumor. 10c. A partial circumferential mucosal inci‐
sion is made. 10d. Submucosal dissection is performed. 10e. The tumor is resected en-bloc. 10f. Resected specimen.
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Figure 11. Perforation during ESD. 11a: 0–IIa 30 mm on the descending colon. 11b. Coagulation to submucosa during
resection of submocosa below the tumor caused perforation (black arrow). 11c: The hole was closed by endoscopic
clipping. 11d: CT revealed free air out side of the colorectum.
Submucosally invasive cancer can be resected by colorectal ESD. A multicenter study of 1111
colorectal ESDs showed that 213 submucosally invasive cancers (19.1%, 213/1111) were treated
clinically by ESD [83]. The rate of submucosally invasive cancer in our institution is 10.2%
(42/410), which is similar to the rates reported in other studies on colorectal ESD (range: 9.2%–
25%)[78-80, 82]. Massively invaded submucosal cancer is not an indication for colorectal ESD
and EMR, because of the possibility of lymph node metastasis. Endoscopic diagnosis of
massively invasive submucosal cancer is limited even when ME for pit patterns, NBI, and FICE
are available. The sensitivity of detail-magnifying observation for massively invasive submu‐
cosal cancer is only 63.8–100.0% [15, 16, 23, 34, 37] (Table 4). Therefore, some number of
massively invasive submucosal cancers may be diagnosed as mucosal cancer or shallowly
invaded submucosal cancer and scheduled for resection by ESD or EMR. In these cases, the
probability of curative resection by ESD is influenced by various clinical features, including
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histopathological vertical margin, lateral margin, and venous-lymphatic invasion. The
characteristics of the submucosally invasive cancers treated at our institution are shown in
Table 7 [74]. The average tumor size was 26.5 mm in the submucosal cancer (SM) group and
35.1 mm in the mucosal cancer (M) group (P < 0.01). The proportion of tumors in the rectum
was higher in the SM group than in the adenoma (A) group (P < 0.01). The ratio of protruding
tumors to superficial tumors was significantly higher in the SM group (14:19) than in the M
group (32:112) or the A group (12:145) (P < 0.01). The rate of severe fibrosis was higher in the
SM group (18.1%) than in the M group (5.5%) (P < 0.05). One cause of severe fibrosis is tumor
invasion. However, mucosal cancers (5.5%) and adenomas (6.0%) also showed severe fibrosis
in our study. Endoscopic biopsy sometimes leads to severe fibrosis. Matsumoto et al. showed
that severe fibrosis complicated ESD and was associated with perforation [89]. The median
operation time for the 7 cases in the SM group with severe fibrosis was 147 min, which was
longer than the M group or the A group. Severe fibrosis is difficult to dissect, and it should be
cautioned that perforation may occur during dissection of severe fibrosis. In our institution,
the clutch cutter, which is a scissor-shaped knife, is used to dissect severe fibrosis with minimal
risk of perforation, as it can grasp, coagulate, and cut a piece of tissue without perioperative
hemorrhage [74].
SM M A P-value
Number of tumors 33 144 157
Median age (range) 65.5 (46–83) 67.9 (48–87) 67.5 (39–87)
M/F 21/12 86/58 81/76 NS
Tumor size (mm) (range) 26.5 (10–60) 35.1 (10–130) 27.0 (10–80) <0.01
Location (Colon/Rectum) 18: 15 87: 57 124: 33 <0.01
SM:A
Morphology (protruding/superficial) 14: 19 32: 112 12: 145 <0.01
Operation time (min) (range) 109 (20–240) 118 (30–420) 92 (10–300) NS
Severe Fibrosis (%) 18.1(7/33) 5.5(8/144) 6.3 10/157) <0.05
SM:M
En bloc resection (%) 90.9 90.9 89.1 NS
Complete resection (%) 72.7 84.0 81.5 NS
Perforation (%) 6.0 7.6 1.9 NS
Postoperative hemorrhage (%) 0 6.2 1.2 NS
ESD: endoscopic submucosal dissection; SM: submucosal cancer; M: mucosal cancer; A: adenoma; NS: not significant
Table 7. Characteristics of colorectal tumors resected by ESD
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11. Training in EMR and ESD
Training in EMR and ESD is important for safe procedures. EMR of small polyps is considered
easy and it is not rare that an inexperienced endoscopist will firstly perform EMR in these
cases. Recently, animal models (Johnson & Johnson K.K., Tokyo, Japan) have become available
for practicing EMR (Figure 12). Some animal model training for inexperienced endoscopists
is used in our institution, and it has had positive impact on EMR in clinical cases. Colorectal
ESD is difficult for less-experienced endoscopists. In general, endoscopists should acquire
extensive experience with gastric ESD before performing colorectal ESD. However, different
training for colorectal ESD is required when the number of patients with early gastric cancer
is few, as in Western countries. In this situation, visiting ESD experts at other institutions and
observing them at work are important components of training. Another expected component
of ESD training is extensive practice using animal models [90-92]. Both in vivo animal models
and ex vivo animal models using harvested organs have been used. Porcine and canine in
vivo models have been reported to be useful systems for ESD training [90-92]. However, in
vivo animal models are expensive and difficult to prepare. Hon et al. demonstrated the
usefulness of a porcine colon ex vivo animal model for training in colorectal ESD [91]. However,
training in endoscopic hemostasis is difficult in conventional ex vivo animal models. We have
recently reported an ex vivo animal model with simulated blood flow (Johnson & Johnson K.K.,
Tokyo, Japan) [93](Figure 12). It can be made using the bovine cecum. The vessel around the
cecum is detached, and red ink is injected. The mucosa shows “blood” flow after the red ink
is injected (Figure 13), which can allow the endoscopist to gain whole ESD experience,
including perioperative hemorrhage (Figure 14). A specific ESD training system has been
implemented in some Japanese institutions, including ours. It is a step-by-step system starting
with observing and assisting in ESD procedures performed by experts. Next, animal model
training is performed to the extent possible. Finally, clinical practice is performed under the
supervision of instructors. Generally, the clinical practice training proceeds according to the
difficulty of the procedure, beginning with gastric ESD, then rectal ESD, and finally colonic
ESD [93]. Regarding animal training in ESD, there are many reports on ex vivo animal models
for gastric ESD [91, 94, 95]. There are also several reports on an ex vivo animal model for
colorectal ESD [92, 93]. Repeated animal model training procedures have recently been proven
to decrease procedure time [91-93]. For clinical colorectal ESD, Hotta et al. showed that
approximately 40 procedures were sufficient to acquire skill in avoiding perforations, and the
perforation rate in the first 40 cases was about 12.5% [96]. We believe that experience obtained
by training on an animal model will also improve performance of clinical colorectal ESD,
although the perforation rate did not decrease to zero even if the skill level improved greatly.
Therefore, we believe the endoscopist must also obtain expertise in endoscopic closure. Small
perforations can be closed by endoscopic clipping [81,97]. However, endoscopic clipping
requires a high level of endoscopic skill and experience, and perforation is relatively rare in
clinical medicine, making it difficult to gain experience in the endoscopic clipping technique
in clinical practice. Ex vivo animal models for perforation are more useful for training in
endoscopic closure than in vivo animal models [93] (Figure 15).
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Figure 12. Animal model training for EMR. 12a. Injection is performed. 12b, 12c. Snaring is performed. 12d. Polyp is
resected by electrocautery.
Figure 13. Ex vivo animal model with blood flow.
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Figure 14. Ex vivo animal model with blood flow. 14a. The submucosal vessels were invisible before injection of red
ink. 14b. The submucosal vessels were visible after injection of red ink.
Figure 15. Ex vivo animal model with blood flow for whole ESD training including endoscopic hemostasis. 15a. Mark‐
ing was performed to mimic the tumor. 15b. Mucosal injection was performed. 15c. Partial circumferential mucosal
incision was performed. 15d. Perioperative hemorrhage was detected. 15e. Submucosal dissection was performed.
15f. En bloc resection was performed.
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Figure 16. Ex vivo animal model with perforation for training of endoscopic closure 16a. After ESD, the endoscopic
knife was used to make a 2–3 mm hole in the proper muscle layer of the ulceration. 16b. The endoscopic closure of
the hole was performed with 4 endoscopic clips.
12. Conclusions
In this chapter, we have described the effectiveness of image-enhanced endoscopy (IEE) and
the safe and definite strategies of therapeutic endoscopy, including endoscopic mucosal
resection (EMR) and endoscopic mucosal dissection (ESD).
Acknowledgements
We thank Dr. Naoki Wakabayashi, Dr. Ken Inoue, and Dr. Yasutaka Morimoto and all
members of the Department of Molecular Gastroenterology and Hepatology, Kyoto Prefec‐
tural University of Medicine, for helping with our study.
Author details
Naohisa Yoshida1*, Nobuaki Yagi1, Yutaka Inada1, Munehiro Kugai1, Akio Yanagisawa2 and
Yuji Naito1
1 Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University
of Medicine, Graduate School of Medical Science, Kyoto, Japan
2 Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Graduate
School of Medical Science, Kyoto, Japan
Endoscopy of GI Tract254
References
[1] Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tu‐
mor development. N Eng J Med 1988; 319:525-532
[2] Kudo S, Hirota S, Nakajima T et al. Colorectal tumours and pit pattern. J Clin Pathol
1994; 47:880-885
[3] Tobaru T, Mitsuyama K, Tsuruta O et al. Sub-classification of type VI pit patterns in
colorectal tumors: relation to the depth of tumor invasion. Int J Oncol 2008;
33:503-508
[4] Fu KI, Sano Y, Kato S, Fujii T, Nagashima F, Yoshino T, Okuno T, Yoshida S, Fuji‐
mori T. Chromoendoscopy using indigo carmine dye spraying with magnifying ob‐
servation is the most reliable method for differential diagnosis between non-
neoplastic and neoplastic colorectal lesions: a prospective study. Endoscopy 2004;
36:1089-1093
[5] Sano Y, Ikematsu H, Fu KI et al. Meshed capillary vessels by use of narrow-band
imaging for differential diagnosis of small colorectal polyps. Gastrointest Endosc
2009; 69:278-283
[6] Togashi K, Osawa H, Koinuma K et al. A comparison of conventional endoscopy,
chromoendoscopy, and the optimal-band imaging system for the differentiation of
neoplastic and non-neoplastic colonic polyps. Gastrointest Endosc 2009; 69:734-741
[7] Uedo N, Higashino K, Ishihara R, Takeuchi Y, Iishi H. Diagnosis of colonic adeno‐
mas by new autofluorescence imaging system. New autofluorescence imaging sys‐
tem: a pilot study. Digestive Endoscopy. 2007; 19:S134-S138
[8] Saito Y, Fukuzawa M, Matsuda T et al. Clinical outcome of endoscopic submucosal
dissection versus endoscopic mucosal resection of large colorectal tumors as deter‐
mined by curative resection. Surg Endosc 2010; 24:343-352
[9] Kudo S, Tamegai Y, Yamano H et al. Endoscopic mucosal resection of the colon: the
Japanese technique. Gastrointest Endosc Clin N Am 2001; 11:519-535
[10] Yoshida N, Naito Y, Yagi N et al. Safe procedure in endoscopic submucosal dissec‐
tion for colorectal tumors focused on preventing complications. World J Gastroenter‐
ol 2010; 16:1688-1695
[11] Rastogi A, Keighley J, Singh V et al. High accuracy of narrow band imaging without
magnification for the real-time characterization of polyp histology and its compari‐
son with high-definition white light colonoscopy: a prospective study. Am J Gastro‐
enterol 2009; 104:2422-2430
Colorectal IEE, EMR, and ESD
http://dx.doi.org/10.5772/52733
255
[12] Konishi K, Kaneko K, Kurahashi T, Yamamoto T, Kushima M, Kanda A, Tajiri H, Mi‐
tamura K. A comparison of magnifying and nonmagnifying colonoscopy for diagno‐
sis of colorectal polyps: A prospective study. Gastrointest Endosc 2003; 57:48-53
[13] Kanao H, Tanaka S, Oka S et al. Narrow-band imaging magnification predicts the
histology and invasion depth of colorectal tumors. Gastrointest Endosc 2009;
69:631-636
[14] Machida H, Sano Y, Hamamoto Y et al. Narrow-band imaging in the diagnosis of
colorectal mucosal lesions: a pilot study. Endoscopy 2004; 36:1094-1098
[15] Ikematsu H, Matsuda T, Emura F et al. Efficacy of capillary pattern type IIIA/IIIB by
magnifying narrow band imaging for estimating depth of invasion of early colorectal
neoplasms. BMC Gastroenterol 2010; 10: 33
[16] Tanaka S, Sano Y. Aim to unify the narrow band imaging (NBI) magnifying classifi‐
cation for colorectal tumors: current status in Japan from a summary of the consen‐
sus symposium in the 79th Annual Meeting of the Japan Gastroenterological
Endoscopy Society. Dig Endosc 2011; Suppl 1:131-9. doi: 10.1111/j.
1443-1661.2011.01106.x.)
[17] Miyake Y, Sekiya T, Kubo S. et al. A new Spectrophotometer for Measuring the Spec‐
tral Reflectance of Gastric Mucous Membrane. J Photographic Science 1989;
37:134-138
[18] Pohl J, Nguyen-Tat M, Pech O et al. Computed virtual chromoendoscopy for classifi‐
cation of small colorectal lesions: a prospective comparative study. Am J Gastroenter‐
ol 2008; 103:562-569
[19] Yoshida N, Naito Y, Inada Y, Kugai M, Inoue K, Uchiyama K, Handa O, Takagi T,
Konishi H, Wakabayashi N, Yagi N, Morimoto Y, Wakabayashi N, Yanagisawa A,
Yoshikawa T. The Detection of Surface Patterns by Flexible Spectral Imaging Color
Enhancement without Magnification for Diagnosis of Colorectal Polyps. Int J Color‐
ectal Dis 2012; 27: 605-611
[20] Togashi K, Sunada K, Yoshida N, et a. Flexible spectral-imaging color enhancement:
optimized settings for polyp detection? Gastrointest Endosc 2011; 74:940
[21] Santos CE, Lima JC, Lopes CV et al. Computerized virtual chromoendoscopy versus
indigo carmine chromoendoscopy combined with magnification for diagnosis of
small colorectal lesions: a randomized and prospective study. Eur J Gastroenterol
Hepatol 2010; 22:1364-1371
[22] Parra-Blanco A, Jiménez A, Rembacken B et al. Validation of Fujinon intelligent chro‐
moendoscopy with high definition endoscopes in colonoscopy. World J Gastroenter‐
ol 2009; 15:5266-5273
Endoscopy of GI Tract256
[23] Yoshida N, Naito Y, Kugai M et al. Efficacy of magnifying endoscopy with flexible
spectral imaging color enhancement in the diagnosis of colorectal tumors. J Gastroen‐
terol 2011; 46: 65-72
[24] Matsuda T, Saito Y, Fu KI, et al. Does autofluorescence imaging videoendoscopy sys‐
tem improve the colonoscopic polyp detection rate?—a pilot study. American Jour‐
nal of Gastroenterology. 2008; 103:1926-1932
[25] McCallum AL, Jenkins JT, Gillen D, Molloy RG. Evaluation of autofluorescence colo‐
noscopy for the detection and diagnosis of colonic polyps. Gastrointestinal Endos‐
copy. 2008; 68:283-290
[26] Tischendorf JJ, Schirin-Sokhan R, Streetz K et al. Value of magnifying endoscopy in
classifying colorectal polyps based on vascular pattern. Endoscopy 2010; 42:22-27
[27] Henry ZH, Yeaton P, Shami VM et al. Meshed capillary vessels found on narrow-
band imaging without optical magnification effectively identifies colorectal neopla‐
sia: a North American validation of the Japanese experience. Gastrointest Endosc
2010; 72:118-126
[28] Rex DK. Narrow-band imaging without optical magnification for histologic analysis
of colorectal polyps. Gastroenterology 2009; 136:1174-1181
[29] Su MY, Hsu CM, Ho YP et al. Comparative study of conventional colonoscopy, chro‐
moendoscopy, and narrow-band imaging systems in differential diagnosis of neo‐
plastic and nonneoplastic colonic polyps. Am J Gastroenterol 2006; 101:2711-2716
[30] Yoshida N, Yagi N, Yanagisawa A, Naito Y. Imaged-enhanced endoscopy for diag‐
nosis of colorectal tumors in view of endoscopic treatment. World J Gastrointest En‐
dosc in press.
[31] Longcroft-Wheaton GR, Higgins B, Bhandari P. Observation of mucosal crypt pattern
with magnifying colonoscopy is superior to nonmagnifying colonoscopy for distin‐
guishing between neoplastic and non-neoplastic colorectal lesions. Eur J Gastroenter‐
ol Hepatol 2011; 23:903-911
[32] Kim YS, Kim D, Chung SJ, Park MJ, Shin CS, Cho SH, Kim JS, Song IS. Differentiat‐
ing small polyp histologies using real-time screening colonoscopy with Fuji Intelli‐
gent Color Enhancement. Clin Gastroenterol Hepatol 2011; 9:744-749
[33] Hewett DG, Kaltenbach T, Sano Y, Tanaka S, Saunders B, Ponchon T, Soetikno R, Rex
DK. Validation of a Simple Classification System for Endoscopic Diagnosis of Small
Colorectal Polyps Using Narrow-Band Imaging. Gastroenterology. 2012 May 15.
[Epub ahead of print]
[34] Wada Y, Kashida H, Kudo SE et al. Diagnostic accuracy of pit pattern and vascular
pattern analyses in colorectal lesions. Dig Endosc 2010; 22:192-199
Colorectal IEE, EMR, and ESD
http://dx.doi.org/10.5772/52733
257
[35] Katagiri A, Fu KI, Sano Y et al. Narrow band imaging with magnifying colonoscopy
as diagnostic tool for predicting histology of early colorectal neoplasia. Aliment
Pharmacol Ther 2008; 27:1269-1274
[36] Singh R, Nordeen N, Mei SL, Kaffes A, Tam W, Saito Y. West meets East: preliminary
results of narrow band imaging with optical magnification in the diagnosis of color‐
ectal lesions: a multicenter Australian study using the modified Sano's classification.
Dig Endosc. 2011 May; 23 Suppl 1:126-30. doi: 10.1111/j.1443-1661.2011.01107.x
[37] Saito S, Tajiri H, Ohya T, Nikami T, Aihara H, Ikegami M. Imaging by Magnifying
Endoscopy with NBI Implicates the Remnant Capillary Network As an Indication for
Endoscopic Resection in Early Colon Cancer. Int J Surg Oncol 2011; 2011:242608.
Epub 2011 Feb 10
[38] Whitlock EP, Lin JS, Liles E, Beil TL, Fu R, O'Connor E, Thompson RN, Cardenas T.
Screening for colorectal cancer: an updated systematic review. Evidence Synthesis
No. 65, Part 1. AHRQ publication no. 08-05124-EF-1. Rockville, MD: Agency for
Healthcare Research and Quality; 2008
[39] Whitlock E, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted
systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;
149
[40] van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss
rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol.
2006; 101:343-350
[41] Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P, Sautereau D,
Boustière C, Grimaud JC, Barthélémy C, Sée J, Serraj I, D'Halluin PN, Branger B, Pon‐
chon T. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of
back-to-back video colonoscopies. Endoscopy. 2008; 40:284-290
[42] Postic G, Lewin D, Bickerstaff C, Wallace MB. Colonoscopic miss rates determined
by direct comparison of colonoscopy with colon resection specimens. Am J Gastroen‐
terol 2002; 97:3182-3185
[43] Morini S, Hassan C, Zullo A, Lorenzetti R, de Matthaeis M, Stella F, Campo SM. De‐
tection of colonic polyps according to insertion/withdrawal phases of colonoscopy.
Int J Colorectal Dis 2009; 24:527-530
[44] Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adeno‐
mas missed by optical colonoscopy. Ann Intern Med 2004; 7;141:352-359
[45] Adler A, Pohl H, Papanikolaou I S, et al. A prospective randomised study on nar‐
row-band imaging versus conventional colonoscopy for adenoma detection: does
narrow-band imaging induce a learning effect? Gut 2008; 57:59-64
Endoscopy of GI Tract258
[46] Adler A, Aschenbeck J, Yenerim T, Mayr M, Aminalai A, Drossel R. Narrow-band
versus white-light high definition television endoscopic imaging for screening colo‐
noscopy: a prospective randomized trial. Gastroenterology 2009; 136:410-416.e1
[47] Rex DK, Helbig CC. High yields of small and flat adenomas with high-definition co‐
lonoscopes using either white light or narrow band imaging. Gastroenterology 2007;
133:42-47
[48] Kaltenbach T, Friedland S, Soetikno R. A randomised tandem colonoscopy trial of
narrow band imaging versus white light examination to compare neoplasia miss
rates. Gut. 2008; 57:1406-1412
[49] Rastogi A, Bansal A, Wani S, Callahan P, McGregor DH, Cherian R, Sharma P. Nar‐
row-band imaging colonoscopy--a pilot feasibility study for the detection of polyps
and correlation of surface patterns with polyp histologic diagnosis. Gastrointest En‐
dosc. 2008; 67:280-286
[50] East JE, Suzuki N, Guenther T, Palmer N, Stavrinidis M, Ignjatovic A, Saunders BP.
Narrow band imaging (NBI) for adenoma detection in high risk patients: a rando‐
mised, controlled trial. Endoscopy. 2009; 41(Suppl 1):A223
[51] Uraoka T, Saito Y, Matsuda T, Sano Y, Ikehara H, Mashimo Y, Kikuchi T, Saito D,
Saito H. Detectability of colorectal neoplastic lesions using a narrow-band imaging
system: a pilot study. J Gastroenterol Hepatol. 2008; 23:1810-1815
[52] Inoue T, Murano M, Murano N, Kuramoto T, Kawakami K, Abe Y, Morita E, Toshina
K, Hoshiro H, Egashira Y, Umegaki E, Higuchi K. Comparative study of convention‐
al colonoscopy and pan-colonic narrow-band imaging system in the detection of neo‐
plastic colonic polyps: a randomized controlled trial. J Gastroenterol 2008; 43:45-50
[53] Jin XF, Chai TH, Shi JW, Yang XC, Sun QY. A meta-analysis for evaluating the accu‐
racy of endoscopy with narrow band imaging in detecting colorectal adenomas. J
Gastroenterol Hepatol. 2011 Nov 18. doi: 10.1111/j.1440-1746.2011.06987.x. [Epub
ahead of print]
[54] Ikematsu H, Saito Y, Tanaka S, Uraoka T, Sano Y, Horimatsu T, Matsuda T, Oka S,
Higashi R, Ishikawa H, Kaneko K. The impact of narrow band imaging for colon pol‐
yp detection: a multicenter randomized controlled trial by tandem colonoscopy. J
Gastroenterol. 2012 Mar 24. [Epub ahead of print]
[55] Sabbagh LC, Reveiz L, Aponte D, de Aguiar S. Narrow-band imaging does not im‐
prove detection of colorectal polyps when compared to conventional colonoscopy: a
randomized controlled trial and meta-analysis of published studies. BMC Gastroen‐
terol. 2011; 11:100
[56] Aminalai A, Rösch T, Aschenbeck J et al. Live image processing does not increase ad‐
enoma detection rate during colonoscopy: a randomized comparison between FICE
Colorectal IEE, EMR, and ESD
http://dx.doi.org/10.5772/52733
259
and conventional imaging (Berlin Colonoscopy Project 5, BECOP-5). Am J Gastroen‐
terol 2010; 105:2383-2388
[57] Chung SJ, Kim D, Song JH et al. Efficacy of computed virtual chromoendoscopy on
colorectal cancer screening: a prospective, randomized, back-to-back trial of Fuji In‐
telligent Color Enhancement versus conventional colonoscopy to compare adenoma
miss rates. Gastrointest Endosc 2010; 72:136-142
[58] Tada M, Shimada, Murakami F et al. Development of the strip-off biopsy [in Japa‐
nese with English abstract]. Gastroenterol Endosc 1984; 26:833-839
[59] Karita M, Tada M, Okita K. The successive strip biopsy partial resection technique
for large early gastric and colon cancers. Gastrointest Endosc 1992; 38:174-178
[60] Saito Y, Fukuzawa M, Matsuda T et al. Clinical outcome of endoscopic submucosal
dissection versus endoscopic mucosal resection of large colorectal tumors as deter‐
mined by curative resection. Surg Endosc 2010; 24:343-352
[61] Tanaka S, Haruma K, Oka S et al. Clinicopathological features and endoscopic treat‐
ment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest
Endosc 2001; 54:62-66
[62] Tajika M, Niwa Y, Bhatia V, et al. Comparison of endoscopic submucosal dissection
and endoscopic mucosal resection for large colorectal tumors. Eur J Gastroenterol
Hepatol 2011; 23:1042-1049
[63] ishi H, Tatsuta M, Iseki K, Narahara H, Uedo N, Sakai N, Ishikawa H, Otani T, Ishi‐
guro S. Endoscopic piecemeal resection with submucosal saline injection of large ses‐
sile colorectal polyps. Gastrointest Endosc 2000; 51:697-700
[64] Kobayashi N, Yoshitake N, Hirahara Y, Konishi J, Saito Y, Matsuda T, Ishikawa T,
Sekiguchi R, Fujimori T. A Matched Case-control Study Comparing Endoscopic Sub‐
mucosal Dissection and Endoscopic Mucosal Resection for Colorectal Tumors. J Gas‐
troenterol Hepatol. 2011 Oct 17. doi: 10.1111/j.1440-1746.2011.06942.x. [Epub ahead of
print]
[65] Uraoka T, Fujii T, Saito Y, Sumiyoshi T, Emura F, Bhandari P, Matsuda T, Fu KI, Sai‐
to D. Effectiveness of glycerol as a submucosal injection for EMR. Gastrointest En‐
dosc 2005; 61:736-740
[66] Lee SH, Cho WY, Kim HJ et al. A new method of EMR: submucosal injection of a fi‐
brinogen mixture. Gastrointest Endosc 2004; 59:220-224
[67] Varadarajulu S, Tamhane A, Slaughter RL. Evaluation of dextrose 50% as a medium
for injection-assisted polypectomy. Endoscopy 2006; 38:907-912
[68] Yamamoto H, Yube T, Isoda N et al. A novel method of endoscopic mucosal resec‐
tion using sodium hyaluronate. Gastrointest Endosc 1999; 50:251-256
Endoscopy of GI Tract260
[69] Yoshida N, Naito Y, Kugai M et al. Efficacy of Hyaluronic Acid in Endoscopic Mu‐
cosal Resection for Colorectal Tumors. J Gastroenterol Hepatol 2011; 26:286-291
[70] Fujishiro M, Yahagi N, Kashimura K, Mizushima Y, Oka M, Enomoto S, et al. Com‐
parison of various submucosal injection solutions for maintaining mucosal elevation
during endoscopic mucosal resection. Endoscopy 2004; 36:579-583
[71] Hyun JJ, Chun HR, Chun HJ, Jeen YT, Baeck CW, Yu SK, et al. Comparison of the
characteristics of submucosal injection solutions used in endoscopic mucosal resec‐
tion. Scand J Gastroenterol 2006; 41:488-492
[72] Hirasaki S, Kozu T, Yamamoto H, Sano Y, Yahagi N, Oyama T, et al. Usefulness and
safety of 0.4% sodium hyaluronate solution as a submucosal fluid "cushion" for en‐
doscopic resection of colorectal mucosal neoplasms: a prospective multi-center open-
label trial. BMC Gastroenterol 2009; 9:1
[73] Yoshida N, Naito Y, Inada Y, Kugai M, Kamada K, Katada K, et al. Efficacy of endo‐
scopic mucosal resection with 0.13% hyaluronic acid solution for colorectal polyps: a
randomized controlled trial. J Gastroenterol Hepatol. In press
[74] Naohisa Yoshida, Yuji Naito, Nobuaki Yagi, Akio Yanagisawa. Importance of Histo‐
logical Evaluation in Endoscopic Submucosal Dissection and Endoscopic Mucosal
Resection for Early Colorectal Cancer. World Journal of Gastrointest Pathophysiol
2012; 3:44-59
[75] Toyonaga T, Man-I M, Morita Y et al. The new resources of treatment for early stage
colorectal tumors: EMR with small incision and simplified endoscopic submucosal
dissection. Dig Endosc 2009; 21 Suppl 1:S31-37
[76] Isomoto H, Nishiyama H, Yamaguchi N et al. Clinicopathological factors associated
with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial
neoplasms. Endoscopy 2009; 41:679-683
[77] Yoshida N, Naito Y, Sakai K et al. Outcome of endoscopic submucosal dissection for
colorectal tumors in elderly people. Int J Colorectal Dis 2010; 25:455-461
[78] Fujishiro M, Yahagi N, Kakushima N et al. Outcomes of endoscopic submucosal dis‐
section for colorectal epithelial neoplasms in 200 consecutive cases. Clin Gastroenter‐
ol Hepatol 2007; 5:678-683
[79] Zhou PH, Yao LQ, Qin XY. Endoscopic submucosal dissection for colorectal epithe‐
lial neoplasm. Surg Endosc. 2009; 23:1546-1551
[80] Tanaka S, Oka S, Kaneko I et al. Endoscopic submucosal dissection for colorectal neo‐
plasia: Possibility of standardization. Gastrointest Endosc 2007; 66:100-107
[81] Yoshida N, Wakabayashi N, Kanemasa K et al. Endoscopic submucosal dissection for
colorectal tumors: technical difficulties and rate of perforation. Endoscopy 2009;
41:758-761
Colorectal IEE, EMR, and ESD
http://dx.doi.org/10.5772/52733
261
[82] Yoshida N, Yagi N, Naito Y, Yoshikawa T. Safe Procedure in Endoscopic Submucosal
Dissection for Colorectal Tumors Focused on Preventing Complications. World J
Gastroenterol 2010; 16: 1688-1695
[83] Saito Y, Uraoka T, Yamaguchi Y, Hotta K, Sakamoto N, Ikematsu H, et al. A prospec‐
tive, multicenter study of 1111 colorectal endoscopic submucosal dissections (with
video). Gastrointest Endosc 2010; 72:1217-1225
[84] Saito Y, Fukuzawa M, Matsuda T, Fukunaga S, Sakamoto T, Uraoka T, Nakajima T,
Ikehara H, Fu KI, Itoi T, Fujii T. Clinical outcome of endoscopic submucosal dissec‐
tion versus endoscopic mucosal resection of large colorectal tumors as determined by
curative resection. Surg Endosc 2009 Jun 11. [Epub ahead of print] PMID: 19517168
[85] Akahoshi K, Motomura Y, Kubokawa M, Matsui N, Oda M, Okamoto R, Endo S, Hi‐
guchi N, Kashiwabara Y, Oya M, Akahane H, Akiba H. Endoscopic submucosal dis‐
section of a rectal carcinoid tumor using grasping type scissors forceps. World J
Gastroenterol 2009;15: 2162-2165
[86] Homma K, Otaki Y, Sugawara M, Kobayashi M. Efficacy of novel SB knife Jr exam‐
ined in a multicenter study on colorectal endoscopic submucosal dissection. Dig En‐
dosc. 2012 May;24 Suppl 1:117-20. doi: 10.1111/j.1443-1661.2012.01266.x.
[87] Yoshida N, Naito Y, Kugai M, Inoue K, Wakabayashi N, Yagi N, Yanagisawa A,
Yoshikawa T. Efficient hemostatic method for endoscopic submucosal dissection of
colorectal tumors. World J Gastroenterol 2010; 16:4180-4186
[88] Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, Kikuchi T, Kozu T,
Saito D. A pilot study to assess the safety and efficacy of carbon dioxide insufflations
during colorectal endoscopic submucosal dissection with the patient under conscious
sedation. Gastrointest Endosc 2007; 65: 537-542
[89] Matsumoto A, Tanaka S, Oba S, Kanao H, Oka S, Yoshihara M, et al. Outcome of en‐
doscopic submucosal dissection for colorectal tumors accompanied by fibrosis. Scand
J Gastroenterol 2010; 45:1329-1337
[90] Tanimoto MA, Torres-Villalobos G, Fujita R, Santillan-Doherty P, Albores-Saavedra
J, Gutierrez G, et al. Endoscopic submucosal dissection in dogs in a World Gastroen‐
terology Organisation training center. World J Gastroenterol 2010; 16:1759-1764
[91] Parra-Blanco A, Arnau MR, Nicolás-Pérez D, Gimeno-García AZ, González N, Díaz-
Acosta JA, et al. Endoscopic submucosal dissection training with pig models in a
Western country. World J Gastroenterol 2010;16:2895-2900
[92] Hon SS, Ng SS, Lee JF, Li JC, Lo AW. In vitro porcine training model for colonic en‐
doscopic submucosal dissection: an inexpensive and safe way to acquire a complex
endoscopic technique. Surg Endosc 2010; 24:2439-2443
Endoscopy of GI Tract262
[93] Yoshida N, Yagi N, Inada Y, Kugai M, Kamada K, Katada K, Uchiyama K, et al. Pos‐
sibility of Ex vivo Animal Training Model for Colorectal Endoscopic Submucosal
Dissection. Int J Colorectal Dis 2012 in press
[94] Vazquez-Sequeiros E, de Miquel DB, Olcina JR, Martin JA, Garcia M, Lucas DJ, et al.
Training model for teaching endoscopic submucosal dissection of gastric tumors.
Rev Esp Enferm Dig 2009; 101:546-552
[95] Yamamoto H. Technology insight: endoscopic submucosal dissection of gastrointes‐
tinal neoplasms. Nat Clin Pract Gastroenterol Hepatol 2007; 4:511-520
[96] Hotta K, Oyama T, Shinohara T, Miyata Y, Takahashi A, Kitamura Y, et al. Learning
curve for endoscopic submucosal dissection of large colorectal tumors. Digestive En‐
doscopy 2010; 22:302-306
[97] Fujishiro M, Yahagi N, Kakushima N, Kodashima S, Muraki Y, Ono S, et al. Success‐
ful nonsurgical management of perforation complicating endoscopic submucosal dis‐
section of gastrointestinal epithelial neoplasms. Endoscopy 2006; 38:1001-1006
Colorectal IEE, EMR, and ESD
http://dx.doi.org/10.5772/52733
263

